Biotech Business - November 7, 2023
Abera Bioscience secures GBP 1.8 million funding
The company has announced the receipt of a funding award from the UK Vaccine Network program. This research program is funded by the Department of Health and Social Care as part of the UK Vaccine Network (UKVN), a UK Aid programme to develop vaccines for diseases with epidemic potential in low and middle-income countries (LMICs). […]
Financing - November 2, 2023
Sigrid Therapeutics secures USD 4 million
The company has successfully secured financing in an oversubscribed funding round. “This funding will propel our efforts in establishing key partnerships and driving SiPore technology to market. We are thrilled to have the backing of our investors as we move closer to providing effective solutions for obesity and diabetes management,” says Sana Alajmovic, Sigrid’s Co-Founder […]
Biotech Business - October 31, 2023
Cantargia raises approximately SEK 59 million
The board of directors of Cantargia has resolved to carry out a directed new issue of 16,698,789 shares at a subscription price of SEK 3.55 per share. The Directed Share Issue will provide Cantargia with approximately SEK 59.3 million before deduction of transaction costs. Investors in the Directed Share Issue represent a variety of Swedish […]
Biotech Business - October 25, 2023
Nykode Therapeutics raises NOK 505 million
The company has announced that a Private Placement has been successfully placed, raising approximately NOK 505 million in gross proceeds through the allocation of 29,549,400 new shares at a subscription price of NOK 17.10 per share. “We are pleased with the strong support Nykode has received from a group of international specialist investors and our […]
Biotech Business - October 19, 2023
Venture forces invest 15 million DKK in Dania Therapeutics
A syndicate consisting of the Lundbeck Foundation BioCapital, EIR Ventures, EIFO and UCPH Ventures, has made an investment in the Danish biotech company Dania Therapeutics. “We are stepping in with strong partners at an early stage, where we can help build and further develop Dania Tx. We know from previous collaborations that Kristian Helin stands […]
Biotech Business - October 10, 2023
Pixelgen Technologies closes Series A financing
Pixelgen has closed a Series A financing of approximately USD 7.3 million. The round was led by new investor Industrifonden, Sweden’s venture capital fund, and Navigare Ventures, an investor in Pixelgen’s Seed round. Proceeds from the financing will support the commercial expansion of Pixelgen’s recently launched spatial proteomics tool for analyzing cell surface proteins on […]
